TherapeuticsMD (TXMD) Change in Account Payables (2010 - 2026)
TherapeuticsMD (TXMD) reported Change in Account Payables of -$340000.0 for Q1 2026, down 314.63% on a YoY basis from $158409.1 in Q1 2025, and down 398.25% quarter-over-quarter from $114000.0 in Q4 2025.
TherapeuticsMD (TXMD) Change in Account Payables (2010 - 2026) Analysis & Trends
TherapeuticsMD has reported Change in Account Payables for 17 years, with the latest figure at -$340000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 314.63% year-over-year to -$340000.0; the trailing twelve-month figure through Mar 2026 stood at -$139000.0 (down 475.68% YoY), and the FY2025 full-year result was $119000.0, down 48.48% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$340000.0, down from $114000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $174000.0 in Q2 2025, with the low at -$818000.0 in Q2 2023.
- Historically, Change in Account Payables has averaged -$196235.3 across 5 years, with a median of -$82000.0 in 2025.
- Annual changes were most pronounced in 2023 — Change in Account Payables sank 946.84% — and 2025, when it soared 4250.0%.
- TherapeuticsMD's Change in Account Payables stood at $79000.0 in 2022, then slumped by 946.84% to -$669000.0 in 2023, then jumped by 103.59% to $24000.0 in 2024, then surged by 375.0% to $114000.0 in 2025, then plunged by 398.25% to -$340000.0 in 2026.
- The last three Change in Account Payables figures came in at -$340000.0 (Q1 2026), $114000.0 (Q4 2025), and -$87000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | TherapeuticsMD | 21,180.42 | -8.40 Mn | - | -340,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -340,000.00 |
| Mar 31, 2026 | -340,000.00 |
| Dec 31, 2025 | 114,000.00 |
| Dec 31, 2025 | 114,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Jun 30, 2025 | 174,000.00 |
| Jun 30, 2025 | 174,000.00 |
| Mar 31, 2025 | -82,000.00 |
| Mar 31, 2025 | -82,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Dec 31, 2023 | -669,000.00 |
| Dec 31, 2023 | -669,000.00 |